Systemic Amyloid Deposits in Familial British Dementia*
暂无分享,去创建一个
T Lashley | T Revesz | A Rostagno | B Frangione | T. Révész | J. Holton | H. Houlden | J. Ghiso | M. Calero | T. Neubert | A. Rostagno | B. Frangione | T. Lashley | R. Vidal | J Holton | R Vidal | M Calero | G Plant | H Houlden | L Miravalle | J A Ghiso | N Wood | T A Neubert | L. Miravalle | N. Wood | Gordon Plant | Gordon T. Plant
[1] R. Bateman,et al. Steady-state kinetics of glutamine cyclotransferase. , 1994, Archives of biochemistry and biophysics.
[2] S. Mead,et al. Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. , 2000, Brain : a journal of neurology.
[3] Agueda Rostagno,et al. A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.
[4] C. Patlak,et al. Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries , 1996, Journal of neurochemistry.
[5] E. Matsubara,et al. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] Jon Thorgeir Hallgrimsson,et al. HEREDITARY CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS , 1972 .
[7] T Bek,et al. A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] C. Masters,et al. The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. , 1981, Brain : a journal of neurology.
[9] B. Frangione,et al. Non-Alzheimer's disease amyloidoses of the nervous system. , 1995, Current opinion in neurology.
[10] D. Dickson,et al. Neurodegenerative diseases with cytoskeletal pathology: A biochemical classification , 1997, Annals of neurology.
[11] S. Love,et al. Familial cerebellar ataxia with cerebrovascular amyloid , 1982, Journal of neurology, neurosurgery, and psychiatry.
[12] J. Sweedler,et al. Formation of N‐Pyroglutamyl Peptides from N‐Glu and N‐Gln Precursors in Aplysia Neurons , 1999, Journal of neurochemistry.
[13] Neil D. Rawlings,et al. Handbook of proteolytic enzymes , 1998 .
[14] D. Steiner,et al. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia , 1999, Nature Neuroscience.
[15] J. Holton,et al. Amyloidogenesis in Familial British Dementia Is Associated with a Genetic Defect on Chromosome 13 , 2000, Annals of the New York Academy of Sciences.
[16] L. Martinian,et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. , 2001, The American journal of pathology.
[17] T. Mandybur,et al. Atypical Gerstmann‐Straüssler syndrome or familial spinocerebellar ataxia and Alzheimer's disease? , 1987, Neurology.
[18] K. Pittois,et al. cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B. , 1998, Gene.
[19] D. Oppenheimer,et al. Congophilic angiopathy of the brain: a clinical and pathological report on two siblings. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[20] J. Holton,et al. Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation , 1999, Acta Neuropathologica.
[21] J. Ghiso,et al. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[22] G. Plant,et al. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. , 1990, Brain : a journal of neurology.
[23] C. Worster-Drought,et al. Familial Presenile Dementia with Spastic Paralysis* , 1933, The Journal of neurology and psychopathology.
[24] H. Vinters. Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.
[25] D. Holtzman,et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.
[26] A. Bateman,et al. Post-translational modification of bovine pro-opiomelanocortin. Tyrosine sulfation and pyroglutamate formation, a mass spectrometric study. , 1990, The Journal of biological chemistry.
[27] Kinuko Suzuki,et al. Atypical Alzheimer's disease with spastic paresis and ataxia , 1985, Annals of neurology.
[28] D. Selkoe,et al. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.
[29] D. Selkoe,et al. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.
[30] D. Yew. Cell kinetic in retinal cell morphogenesis , 1979, Neuroscience Letters.
[31] The genetics of neurological disorders , 1982 .
[32] Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.
[33] W. Busby,et al. An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. , 1987, The Journal of biological chemistry.
[34] W. Markesbery,et al. N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.